A Novel Strategy of US3 Codon De-Optimization for Construction of an Attenuated Pseudorabies Virus against High Virulent Chinese Pseudorabies Virus Variant

文献类型： 外文期刊

第一作者： Xu, Mengwei

作者： Xu, Mengwei;Wang, Yiwei;Liu, Yamei;Chen, Saisai;Tong, Ling;Zheng, Yating;Zhang, Chuanjian;Wang, Jichun;Xu, Mengwei;Wang, Yiwei;Liu, Yamei;Chen, Saisai;Tong, Ling;Zheng, Yating;Zhang, Chuanjian;Wang, Jichun;Xu, Mengwei;Wang, Yiwei;Liu, Yamei;Chen, Saisai;Tong, Ling;Zheng, Yating;Zhang, Chuanjian;Wang, Jichun;Xu, Mengwei;Wang, Yiwei;Liu, Yamei;Chen, Saisai;Tong, Ling;Zheng, Yating;Zhang, Chuanjian;Wang, Jichun;Xu, Mengwei;Zhu, Laixu;Osterrieder, Nikolaus

作者机构：

关键词： pseudorabies virus; virulence; safety; immunogenicity; codon de-optimization

期刊名称：VACCINES （ 影响因子：7.8； 五年影响因子：7.4 ）

ISSN：

年卷期： 2023 年 11 卷 8 期

页码：

收录情况： SCI

摘要： In this study, we applied bacterial artificial chromosome (BAC) technology with PRVATK/gE/gI as the base material to replace the first, central, and terminal segments of the US3 gene with codon-deoptimized fragments via two-step Red-mediated recombination in E. coli GS1783 cells. The three constructed BACs were co-transfected with gI and part of gE fragments carrying homologous sequences (gI+gE'), respectively, in swine testicular cells. These three recombinant viruses with US3 codon de-optimization ((PRVATK & gE-US3deop-1, PRVATK & gE-US3deop-2, and PRVATK & gE-US3deop-3) were obtained and purified. These three recombinant viruses exhibited similar growth kinetics to the parental AH02LA strain, stably retained the deletion of TK and gE gene fragments, and stably inherited the recoded US3. Mice were inoculated intraperitoneally with the three recombinant viruses or control virus PRVATK & gEAH02 at a 107.0 TCID50 dose. Mice immunized with PRVATK & gE-US3deop-1 did not develop clinical signs and had a decreased virus load and attenuated pathological changes in the lungs and brain compared to the control group. Moreover, immunized mice were challenged with 100 LD50 of the AH02LA strain, and PRVATK & gE-US3deop-1 provided similar protection to that of the control virus PRVATK & gEAH02. Finally, PRVATK & gE-US3deop-1 was injected intramuscularly into 1-day-old PRV-negative piglets at a dose of 106.0 TCID50. Immunized piglets showed only slight temperature reactions and mild clinical signs. However, high levels of seroneutralizing antibody were produced at 14 and 21 days post-immunization. In addition, the immunization of PRVATK & gE-US3deop-1 at a dose of 105.0 TCID50 provided complete clinical protection and prevented virus shedding in piglets challenged by 106.5 TCID50 of the PRV AH02LA variant at 1 week post immunization. Together, these findings suggest that PRVATK & gE-US3deop-1 displays great potential as a vaccine candidate.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序